Donor Lymphocyte Infusion Induces Polyspecific CD8⁺ T-Cell Responses With Concurrent Molecular Remission in Acute Myeloid Leukemia With <i>NPM1</i> Mutation

Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [see comments]

HJ Kolb, A Schattenberg, JM Goldman et al. · Blood · 1995 · 2K citations · Full text

Medicine, Hematology, Immunology +16

Donor Lymphocyte Infusion in the Treatment of First Hematological Relapse After Allogeneic Stem-Cell Transplantation in Adults With Acute Myeloid Leukemia: A Retrospective Risk Factors Analysis and Comparison With Other Strategies by the EBMT Acute Leukemia Working Party

Christoph Schmid, Myriam Labopin, Arnon Nagler et al. · Journal of Clinical Oncology · 2007 · 516 citations · Full text

Medicine, Hematology, Immunology +17

Monitoring of Minimal Residual Disease in <i>NPM1</i> -Mutated Acute Myeloid Leukemia: A Study From the German-Austrian Acute Myeloid Leukemia Study Group

Jan Krönke, Richard F. Schlenk, Kai‐Ole Jensen et al. · Journal of Clinical Oncology · 2011 · 394 citations · Full text

Medicine, Hematology, Oncology +15

Leukemia-associated antigen-specific T-cell responses following combined PR1 and WT1 peptide vaccination in patients with myeloid malignancies

Katayoun Rezvani, Agnes S. M. Yong, Stephan Mielke et al. · Blood · 2007 · 339 citations · Full text

Medicine, Immunology, Oncology +14

Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells

Jeffrey J. Molldrem, Said Dermime, Kenneth C. Parker et al. · Blood · 1996 · 330 citations · Full text

Life Sciences, Immunology, Oncology +17